RESUMO
Heterotrimeric G proteins are key mediators in the signaling of G protein-coupled receptors (GPCR) that are involved in a plethora of important physiological processes and thus major targets of pharmaceutical drugs. The cyclic depsipeptides YM-254890 and FR900359 are strong and selective inhibitors of the Gq subfamily of G proteins. FR900359 was first reported to be produced by unculturable plant symbiont, however, a culturable FR900359 producer was discovered recently by the standard strategy, screening of the producing strain from the environment. As another strategy, we introduce herein the different way to supply natural compounds of unculturable microorganism origin. We therefore embarked on constructing an artificial biosynthetic gene cluster (BGC) for FR900359 with YM-254890 BGC as a template using "in vitro module editing" technology, first developed for the modification of type-I PKS BGCs, to edit YM-254890 BGC. The resulting artificial BGCs coding FR900359 were heterologously expressed in the Pseudomonas putida KT2440 host strain.
Assuntos
Antineoplásicos , Depsipeptídeos , Subunidades alfa Gq-G11 de Proteínas de Ligação ao GTP/metabolismo , Depsipeptídeos/química , Receptores Acoplados a Proteínas G/metabolismoRESUMO
Verticilactam and the new geometric isomers, verticilactams B and C, were produced by heterologous expression of the biosynthetic gene cluster for verticilactam using the Streptomyces avermitilis SUKA17 strain. Only verticilactam, a compound with a characteristic ß-ketoamide unit within a 16-membered polyketide macrolactam conjugated with an octalin skeleton, had been previously reported having been isolated from Streptomyces spiroverticillatus JC-8444. In this report, minor verticilactam derivatives were isolated from the transformed strain, and their structures elucidated by spectral analysis. Verticilactam B was a geometric isomer at Δ17 and Δ19, and verticilactam C was the Δ19 and Δ21 isomer. In addition, the absolute configuration of verticilactam was confirmed by ECD analysis and NMR chemical shifts. The stereochemistry assignments of the hydroxy groups at C-10 and C-12 were supported by the domain organization of the polyketide synthase identified in the verticilactam gene cluster. Verticilactam showed moderate activity against the malaria parasite Plasmodium falciparum 3D7 strain with no significant cytotoxicity or antimicrobial effects.
Assuntos
Lactamas/metabolismo , Macrolídeos/metabolismo , Família Multigênica , Streptomyces/química , Espectroscopia de Ressonância Magnética/métodosRESUMO
Quinolidomicin A1 is the largest macrolide compound from terrestrial sources, consisting of a 60-membered ring, and its biosynthetic gene cluster was revealed to be over 200 kb. The gene cluster for quinolidomicin was cloned and heterologously expressed. Confirmation of the product led to a structural revision, in which the hydroxy group in the chromophore moiety of the reported structure was replaced by an amine group.
Assuntos
Antibacterianos/biossíntese , Macrolídeos/metabolismo , Streptomyces lividans/genética , Antibacterianos/química , Macrolídeos/química , Conformação Molecular , Família MultigênicaRESUMO
Telomestatin, a strong telomerase inhibitor with G-quadruplex stabilizing activity, is a potential therapeutic agent for treating cancers. Difficulties in isolating telomestatin from microbial cultures and in chemical synthesis are bottlenecks impeding the wider use. Therefore, improvement in telomestatin production and structural diversification are required for further utilization and application. Here, we discovered the gene cluster responsible for telomestatin biosynthesis, and achieved production of telomestatin by heterologous expression of this cluster in the engineered Streptomyces avermitilis SUKA strain. Utilization of an optimal promoter was essential for successful production. Gene disruption studies revealed that the tlsB, tlsC, and tlsO-T genes play key roles in telomestatin biosynthesis. Moreover, exchanging TlsC core peptide sequences resulted in the production of novel telomestatin derivatives. This study sheds light on the expansion of chemical diversity of natural peptide products for drug development.
Assuntos
Inibidores Enzimáticos/farmacologia , Família Multigênica , Oxazóis/metabolismo , Regiões Promotoras Genéticas , Streptomyces/metabolismo , Telomerase/antagonistas & inibidores , Oxazóis/química , Streptomyces/genética , Streptomyces/crescimento & desenvolvimentoRESUMO
Macrolactam antibiotics such as incednine and cremimycin possess an aliphatic ß-amino acid as a starter unit of their polyketide chain. In the biosynthesis of incednine and cremimycin, unique stand-alone adenylation enzymes IdnL1 and CmiS6 select and activate the proper aliphatic ß-amino acid as a starter unit. In this study, we describe the enzymatic characterization and the structural basis of substrate specificity of IdnL1 and CmiS6. Functional analysis revealed that IdnL1 and CmiS6 recognize 3-aminobutanoic acid and 3-aminononanoic acid, respectively. We solved the X-ray crystal structures of IdnL1 and CmiS6 to understand the recognition mechanism of these aliphatic ß-amino acids. These structures revealed that IdnL1 and CmiS6 share a common recognition motif that interacts with the ß-amino group of the substrates. However, the hydrophobic side-chains of the substrates are accommodated differently in the two enzymes. IdnL1 has a bulky Leu220 located close to the terminal methyl group of 3-aminobutanoate of the trapped acyl-adenylate intermediate to construct a shallow substrate-binding pocket. In contrast, CmiS6 possesses Gly220 at the corresponding position to accommodate 3-aminononanoic acid. This structural observation was supported by a mutational study. Thus, the size of amino acid residue at the 220 position is critical for the selection of an aliphatic ß-amino acid substrate in these adenylation enzymes. Proteins 2017; 85:1238-1247. © 2017 Wiley Periodicals, Inc.
Assuntos
Diamino Aminoácidos/química , Aminobutiratos/química , Proteínas de Bactérias/química , Nucleotidiltransferases/química , Streptomyces/química , Motivos de Aminoácidos , Diamino Aminoácidos/metabolismo , Aminobutiratos/metabolismo , Antibacterianos/biossíntese , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Sítios de Ligação , Clonagem Molecular , Cristalografia por Raios X , Dissacarídeos/biossíntese , Escherichia coli/genética , Escherichia coli/metabolismo , Expressão Gênica , Cinética , Lactamas/metabolismo , Modelos Moleculares , Nucleotidiltransferases/genética , Nucleotidiltransferases/metabolismo , Ligação Proteica , Conformação Proteica em alfa-Hélice , Conformação Proteica em Folha beta , Domínios e Motivos de Interação entre Proteínas , Estrutura Terciária de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Streptomyces/enzimologia , Homologia Estrutural de Proteína , Especificidade por SubstratoRESUMO
Cremimycin is a 19-membered macrolactam glycoside antibiotic based on three distinctive substructures: 1) a ß-amino fatty acid starter moiety, 2) a bicyclic macrolactam ring, and 3) a cymarose unit. To elucidate the biosynthetic machineries responsible for these three structures, the cremimycin biosynthetic gene cluster was identified. The cmi gene cluster consists of 33 open reading frames encoding eight polyketide synthases, six deoxysugar biosynthetic enzymes, and a characteristic group of five ß-amino-acid-transfer enzymes. Involvement of the gene cluster in cremimycin production was confirmed by a gene knockout experiment. Further, a feeding experiment demonstrated that 3-aminononanoate is a direct precursor of cremimycin. Two characteristic enzymes of the cremimycin-type biosynthesis were functionally characterized in vitro. The results showed that a putative thioesterase homologue, CmiS1, catalyzes the Michael addition of glycine to the ß-position of a non-2-enoic acid thioester, followed by hydrolysis of the thioester to give N-carboxymethyl-3-aminononanoate. Subsequently, the resultant amino acid was oxidized by a putative FAD-dependent glycine oxidase homologue, CmiS2, to produce 3-aminononanoate and glyoxylate. This represents a unique amino transfer mechanism for ß-amino acid biosynthesis.